Tel: (857) 239-0968 / (617) 419-7131
Home > VEGFR
Cat.No. Product Name Information Area
T4094 Anlotinib Dihydrochloride Anlotinib, also known as AL3818, is a receptor tyrosine kinase (RTK) inhibitor with p... Cancer
T4026 VEGFR2 KiN/Ase Inhibitor I Vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR and FLK1) is... Others
T3980 Su1498 SU 1498 is a selective inhibitor of the receptor tyrosine kinase VEGF receptor 2 (VEG... Others
T3571 NSC 247030 NSC 247030 is a biochemical. Others
T3560 Desmethylanethol trithione ADT-OH is a derivative of anethole dithiolethione (ADT) and synthetic hydrogen sulfid... Others
T3463 ACC-789 (NVP-ACC789) ACC-789, also known as NVP-ACC789 and ZK-202650, is a potent, selective and orally ac... Others
T3476 JI-101 JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth fac... Cardiovascular
T3691 SAR131675 SAR131675 is a potent and selective VEGFR-3 inhibitor. It inhibited VEGFR-3 tyrosine ... Others
T3599 BFH772 BFH772, a structure analogue of BAW2881, is a potent and selective VEGF inhibitor. BF... Immunology
T3641 BAW2881 BAW2881 is a potent and selective VEGFR inhibitor (vascular endothelial growth factor... Others
T6996 SU5402 SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 ... Others
T6930 Pazopanib HCl (GW786034 HCl) Pazopanib HCl (GW786034 HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEG... Others
T1797 XL184(Cabozantinib malate) Cabozantinib S-malate is the s-malate salt form of cabozantinib, an orally bioavailab... Cancer
T2288 Motesanib Motesanib is an orally bioavailable receptor tyrosine kinase inhibitor with potential... Cancer
T6720 Vatalanib (PTK787) diHydrochloride Vatalanib (PTK787) is an inhibitor of VEGFR2/KDR with IC50 of 37 nM, less potent agai... Cancer
T6184 TSU-68 TSU-68 (SU6668, Orantinib) has greatest potency against PDGFR autophosphorylation wit... Cancer
T6166 Telatinib Telatinib is a potent inhibitor of VEGFR2/3, c-Kit and PDGFRα with IC50 of 6 nM/4 nM,... Cancer
T6036 Brivanib Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, moderate ... Cancer
T3068 AT9283 AT9283 is a potent JAK2/3 inhibitor with IC50 of 1.2 nM/1.1 nM in cell-free assays; a... Cancer
T2699 BMS-777607 BMS-777607 is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3 with IC50 of 3.9 ... Endocrine system
T2656 Fruquintinib Fruquintinib (HMPL-013) is a small molecule vascular endothelial growth factor recept... Cancer
T2642 PD173074 PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 wit... Cancer
T2620 G-749 G-749 is a novel and potent FLT3 inhibitor with IC50 of 0.4 nM, 0.6 nM and 1 nM for F... Cardiovascular System
T2586 Cabozantinib Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM a... Cancer
T2582 Apatinib Apatinib is an orally bioavailable, selective VEGFR2 inhibitor with IC50 of 1 nM. Cancer
T2576 Brivanib alaninate Brivanib alaninate (BMS-582664) is the prodrug of BMS-540215, an ATP-competitive inhi... Cancer
T2514 Linifanib Linifanib (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR,... Cancer
T2500 Cediranib Cediranib (AZD2171) is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM, also ... Cancer
T2496 Semaxanib (SU5416) Semaxanib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor with IC50 of ... Cancer
T2456 Tivozanib Tivozanib is an orally bioavailable inhibitor of vascular endothelial growth factor r... Cancer